首页   按字顺浏览 期刊浏览 卷期浏览 Phase II Trial of Oral Idarubicin in Advanced Non-Small Cell Lung Cancer (NSCLC)
Phase II Trial of Oral Idarubicin in Advanced Non-Small Cell Lung Cancer (NSCLC)

 

作者: ArdizzoniAndrea,   PronzatoPaolo,   RepettoLazzaro,   De PalmaMario,   CanobbioLuciano,   GulisanoMarcella,   FuscoVittorio,   RossoRiccardo,   GanzinaFranco,  

 

期刊: Cancer Investigation  （Taylor Available online 1988）
卷期: Volume 6, issue 4  

页码: 409-411

 

ISSN:0735-7907

 

年代: 1988

 

DOI:10.3109/07357908809080069

 

出版商: Taylor&Francis

 

数据来源: Taylor

 

摘要:

AbstractThe antitumoral activity and toxicity of a new daunorubicin analog (4-demethoxydaunorubicin, IMI30, Idarubicin) was tested in 20 consecutive patients with non-small cell lung cancer mostly pretreated with chemotherapy. The drug was administered orally at a dose of 15 mg/m2for three days every 3-4 weeks. There were no clinical responses. Hematological and nonhematobgical toxicities were mild.

 

点击下载:  PDF (210KB)



返 回